These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prioritizing and modelling of putative drug target proteins of Candida albicans by systems biology approach. Ismail T; Fatima N; Muhammad SA; Zaidi SS; Rehman N; Hussain I; Tariq NUS; Amirzada I; Mannan A Acta Biochim Pol; 2018; 65(2):209-218. PubMed ID: 29913479 [TBL] [Abstract][Full Text] [Related]
6. Genomic identification of potential targets unique to Candida albicans for the discovery of antifungal agents. Tripathi H; Luqman S; Meena A; Khan F Curr Drug Targets; 2014 Jan; 15(1):136-49. PubMed ID: 24102473 [TBL] [Abstract][Full Text] [Related]
7. Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target. Demuyser L; Palmans I; Vandecruys P; Van Dijck P mSphere; 2020 Aug; 5(4):. PubMed ID: 32759338 [No Abstract] [Full Text] [Related]
8. Translation Inhibition by Rocaglates Activates a Species-Specific Cell Death Program in the Emerging Fungal Pathogen Candida auris. Iyer KR; Whitesell L; Porco JA; Henkel T; Brown LE; Robbins N; Cowen LE mBio; 2020 Mar; 11(2):. PubMed ID: 32156828 [TBL] [Abstract][Full Text] [Related]
9. Histone acetylation/deacetylation in Su S; Li X; Yang X; Li Y; Chen X; Sun S; Jia S Future Microbiol; 2020 Jul; 15():1075-1090. PubMed ID: 32854542 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis. Zeng YB; Qian YS; Ma L; Gu HN Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123 [TBL] [Abstract][Full Text] [Related]
11. Antifungal Activity of Mammalian Serum Amyloid A1 against Gong J; Wu J; Ikeh M; Tao L; Zhang Y; Bing J; Nobile CJ; Huang G Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685470 [TBL] [Abstract][Full Text] [Related]
12. Emodin Reduces the Activity of (1,3)- Janeczko M Pol J Microbiol; 2018; 67(4):463-470. PubMed ID: 30550232 [TBL] [Abstract][Full Text] [Related]
13. Genomics strategies for antifungal drug discovery--from gene discovery to compound screening. Willins DA; Kessler M; Walker SS; Reyes GR; Cottarel G Curr Pharm Des; 2002; 8(13):1137-54. PubMed ID: 12052224 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial sorting and assembly machinery subunit Sam37 in Candida albicans: insight into the roles of mitochondria in fitness, cell wall integrity, and virulence. Qu Y; Jelicic B; Pettolino F; Perry A; Lo TL; Hewitt VL; Bantun F; Beilharz TH; Peleg AY; Lithgow T; Djordjevic JT; Traven A Eukaryot Cell; 2012 Apr; 11(4):532-44. PubMed ID: 22286093 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide screening and in silico gene knockout to predict potential candidates for drug designing against Candida albicans. Verma R; Pradhan D; Maseet M; Singh H; Jain AK; Khan LA Infect Genet Evol; 2020 Jun; 80():104196. PubMed ID: 31954918 [TBL] [Abstract][Full Text] [Related]
17. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen DeJarnette C; Luna-Tapia A; Estredge LR; Palmer GE mSphere; 2020 Jun; 5(3):. PubMed ID: 32581079 [TBL] [Abstract][Full Text] [Related]
18. Advances in fungal chemical genomics for the discovery of new antifungal agents. Xue A; Robbins N; Cowen LE Ann N Y Acad Sci; 2021 Jul; 1496(1):5-22. PubMed ID: 32860238 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Candida albicans growth by brominated furanones. Duo M; Zhang M; Luk YY; Ren D Appl Microbiol Biotechnol; 2010 Feb; 85(5):1551-63. PubMed ID: 19756586 [TBL] [Abstract][Full Text] [Related]
20. Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms. Mitchell KF; Taff HT; Cuevas MA; Reinicke EL; Sanchez H; Andes DR Antimicrob Agents Chemother; 2013 Apr; 57(4):1918-20. PubMed ID: 23318790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]